History of poliomyelitis: from elimination to the risk of reintroduction
Keywords:Disease eradication; Immunization; Polio; Vaccines.
Immunization is validated as one of the most successful and tangible actions, which actually result in the control and eradication of numerous pathologies across the planet. Despite this, the decrease in the vaccination coverage rate in Brazil and in the world is quite worrying, and may lead to the reintroduction of diseases that were previously controlled and eliminated. In view of this, with the objective of carrying out an analysis of the situation of the different regions of the earth, considering their disparities, the current work highlights areas with a reduction in the rate of vaccination coverage against poliomyelitis since 2016. An integrative review of literature, searching articles published between the years 2018 to 2022, in Spanish, English and Portuguese. The results observed in the 20 articles showed that Afghanistan and Pakistan are the only countries that are not polio free. In addition, the COVID-19 pandemic helped to accentuate the reduction in the vaccination rate in Brazil and in the world. With this, the decrease in vaccination coverage evidenced since 2016 confirms the relevance of this study, highlighting the importance of having a greater degree of understanding on the subject, in addition to more effective actions to increase vaccination coverage, such as public health campaigns.
Alfonso, V. H., Voorman, A., Hoff, N. A., Weldon, W. C., Gerber, S., Gadoth, A., ... & Rimoin, A. W. (2022). Poliovirus immunity among adults in the Democratic Republic of the Congo: a cross-sectional serosurvey. BMC infectious diseases, 22(1), 1-8.
Al-Qassimi, M. A., Al Amad, M., Anam, L., Almoayed, K., Al-Dar, A., & Ezzadeen, F. (2022). Circulating vaccine derived polio virus type 1 outbreak, Saadah governorate, Yemen, 2020. BMC infectious diseases, 22(1), 1-11.
Andersen, A., Fisker, A. B., Nielsen, S., Rodrigues, A., Benn, C. S., & Aaby, P. (2021). National immunization campaigns with oral polio vaccine may reduce all-cause mortality: An analysis of 13 years of demographic surveillance data from an urban African area. Clinical Infectious Diseases, 72(10), e596-e603.
Arroyo, L. H., Ramos, A. C. V., Yamamura, M., Weiller, T. H., Crispim, J. D. A., Cartagena-Ramos, D., ... & Arcêncio, R. A. (2020). Áreas com queda da cobertura vacinal para BCG, poliomielite e tríplice viral no Brasil (2006-2016): mapas da heterogeneidade regional. Cadernos de Saúde Pública, 36.
Aziz, A. B., Verma, H., Jeyaseelan, V., Yunus, M., Nowrin, S., Moore, D. D., ... & Zaman, K. (2022). One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh. The Journal of Infectious Diseases, 226(8), 1319-1326.
Badizadegan, K., Kalkowska, D. A., & Thompson, K. M. (2022). Polio by the Numbers—A Global Perspective. The Journal of infectious diseases, 226(8), 1309-1318.
Bassoum, O., Sougou, N. M., Ba, M. F., Anne, M., Bocoum, M., Dieye, A., ... & Tal-Dia, A. (2022). Vaccination against tuberculosis, polio and hepatitis B at birth in Podor health district, Northern Senegal: cross-sectional study of vaccination coverage and its associated factors. BMC public health, 22(1), 1-13.
Din, M., Ali, H., Khan, M., Waris, A., Ullah, S., Kashif, M., ... & Ali, M. (2021). Impact of COVID‐19 on polio vaccination in Pakistan: a concise overview. Reviews in medical virology, 31(4), e2190.
Faye, M., Kébé, O., Diop, B., Ndiaye, N., Dosseh, A., Sam, A., ... & Faye, O. (2022). Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020-2021. Emerging infectious diseases, 28(10), 2027-2034.
Link-Gelles, R. (2022). Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater—New York, June–August 2022. MMWR. Morbidity and Mortality Weekly Report, 71.
Mbaeyi, C. (2022). Progress Toward Poliomyelitis Eradication—Pakistan, January 2021–July 2022. MMWR. Morbidity and Mortality Weekly Report, 71.
Moraes, J. C. D., Rujula, M. J. P., & Otsuka, M. (2021). PREVALÊNCIA DE ANTICORPOS NEUTRALIZANTES CONTRA POLIOVÍRUS 1, 2 E 3 EM PROFISSIONAIS DE SAÚDE DE 20 A 50 ANOS DE IDADE. Revista Paulista de Pediatria, 39.
Rachlin, A., Patel, J. C., Burns, C. C., Jorba, J., Tallis, G., O’Leary, A., ... & Vertefeuille, J. F. (2022). Progress Toward Polio Eradication—Worldwide, January 2020–April 2022. Morbidity and Mortality Weekly Report, 71(19), 650.
Rodrigues, R. N., Nascimento, G. L. M. D., Arroyo, L. H., Arcêncio, R. A., Oliveira, V. C. D., & Guimarães, E. A. D. A. (2022). Pandemia por COVID-19 e o abandono da vacinação em crianças: mapas da heterogeneidade espacial. Revista Latino-Americana de Enfermagem, 30.
Sadigh, K. S., Akbar, I. E., Wadood, M. Z., Shukla, H., Jorba, J., Chaudhury, S., & Martinez, M. (2022). Progress Toward Poliomyelitis Eradication―Afghanistan, January 2020–November 2021. Morbidity and Mortality Weekly Report, 71(3), 85.
Sato, A. P. S. (2018). Qual a importância da hesitação vacinal na queda das coberturas vacinais no Brasil?. Revista de Saúde Pública, 52.
Silva, F. D. S., Barbosa, Y. C., Batalha, M. A., Ribeiro, M. R. C., Simões, V. M. F., Branco, M. D. R. F. C., ... & Silva, A. A. M. D. (2018). Incompletude vacinal infantil de vacinas novas e antigas e fatores associados: coorte de nascimento BRISA, São Luís, Maranhão, Nordeste do Brasil. Cadernos de Saúde Pública, 34.
Souza, N. E., de Oliveira Afonso, E., & Calmon, A. B. (2018). Síndrome de Guillain-Barré e sua relação com o calendário vacinal brasileiro: uma revisão de literatura. Revista Brasileira de Neurologia, 54(1), 39-45.
Verani, J. F. D. S., & Laender, F. (2020). A erradicação da poliomielite em quatro tempos. Cadernos de Saúde Pública, 36.
Wilkinson, A. L., Diop, O. M., Jorba, J., Gardner, T., Snider, C. J., & Ahmed, J. (2022). Surveillance to track progress toward polio eradication—worldwide, 2020–2021. Morbidity and Mortality Weekly Report, 71(15), 538.
How to Cite
Copyright (c) 2023 Maria Eduarda Silva Lima Verde Santos; Juliana Alves Rodrigues; Tânia Aparecida de Araújo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.